References
- Cross C E, van der Vliet A, O'Neill C A, Louie S, Halliwell B. Oxidants, antioxidants and respiratory tract lining fluids. Environ Health Perspect 1994; 102: 185–91, Suppl 10
- Heffner J E, Repine JE. Pulmonary strategies of antioxidant defence. Am Rev Respir Dis 1989; 140: 531–54
- Ben-Jebria A, Kabel J, Ultman JS. Regional human lung dosimetry of inhaled ozone: the scrubbing efficiency of the nose. Inhalation Toxicology 1994; 386–9, Suppl 6
- Gerrity T R, Weister MJ. Experimental measurements of the uptake of ozone in rats and human subjects. 80th Annual meeting of APCA. New York June 21-26, 1986
- Peden D B, Hohman R, Brown M E, et al. Uric acid is a major antioxidant in human nasal airway secretions. Proc Natl Acad Sci USA 1990; 87: 7638–42
- Housley D G, Mudway I, Kelly F J, Eccles R, Richards RJ. Depletion of urate in human nasal lavage following in vitro ozone exposure. Int J Biochem Cell Biol 1995; 27: 1153–9
- Ames B N, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defence in humans against oxidant and free radical caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858–62
- Smith R C, Gore J Z, Doyle MP. Degradation of uric acid during autocatalytic oxidation of oxyhemoglobin by sodium nitrite. Free Radic Biol Med 1991; 11: 373–7
- Simic M G, Jovanovic SV. Antioxidant mechanisms of uric acid. J Am Chem Soc 1989; 111: 5778–82
- Cross C E, Motchnik P A, Bruener B A, et al. Oxidative damage to plasma constituents by ozone. FEBS 1992; 298: 269–72
- Hatch GE. Ozone ditribution in the lung: studies with ozone (abstract). Respir Med 1994; 88: 817–8
- Advisory group on the medical aspects of air pollution episodes. First report ozone. HMSO. 1991
- Housley D G, Eccles R, Richards RJ. Antioxidants and biotransformation potential in human nasal lavage. Inhalation Toxicology 1994; Vol 6: 369–71, Suppl
- Lowry O H, Rosebrough N J, Fair A L, Randall RJ. Protein measurement with the Folin Phenol reagent. J Biol Chem 1951; 193: 265–76
- Metcalf J A, Gallin J I, Nauseef W M, Root RK. Laboratory manual of neutrophil function. Raven Press, New York 1986; 149–50
- Kauffmann F, Annesi I, Neukirch F, Oryszczyn M P, Alperovitch A. The relation between snoring and smoking, body mass index, age, alcohol consumption and respiratory symptoms. Eur Respir J 1989; 2: 599–603
- Vig P S, Zajac DJ. Age and gender effects on nasal respiratory function in normal subjects. Cleft Palate Craniofac. J 1993; 30: 279–84
- Syabolo N C, Bundgaard A, Entholm P, Schmidt A, Widicombe JG. Measurement and regulation of nasal airflow resistance in man. Rhinology 1986; 24: 87–101
- Getchell M L, Chen Y, Ding X, Sparks D L, Getchell TV. Immunohistochemical localisation of a cytochrome P450 isozyme in human nasal mucosa: age-related trends. Ann Otol Rhinol Laryngol 1993; 102: 368–74
- Peden D B, Swiersz Z M, Ohkubo K, Hahn B, Emery B, Kaliner MA. Nasal secretion of the ozone scavenger uric acid. Am Rev Respir Dis 1993; 148: 455–61
- Young DS. Effects of drugs on clinical laboratory tests. AACC Press, Washington DC 1990; 3/360–3/369
- Mackie A, Seal DV. Diagnostic implications of tear protein profiles. Br J Ophthalmol 1984; 68: 321–4
- Pryor WA. How far does ozone penetrate the pulmonary air/tissue boundary before it reacts?. Free Radic Biol Med 1992; 12: 83–8
- Messineo T D, Adams WC. Ozone inhalation effects in females varying widely in lung size: comparison with males. J Appl Physiol 1990; 69: 96–103
- Koren H S, Devlin RB. Human upper respiratory tract responses to inhaled pollutants with emphasis on nasal lavage. Ann NY Acad Sci 1992; 641: 215–24